CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
CCAAT enhancer binding protein alpha (CEBPA) gene is located on the long (q) arm of chromosome 19 (position 13.11). CCAAT/enhancer-binding protein alpha (CEBPA) is a transcription factor and plays important role in cellular differentiation and growth. It is expressed in myeloid precursors during hematopoiesis.
Mutations of CEBPA can be familial or sporadic and lead to acute myeloid leukemia. Germline mutations show autosomal dominant pattern of inheritance with complete to near complete penetrance and are implicated in Familial acute myeloid leukemia with mutated CEBPA.
Cases of Familial acute myeloid leukemia with mutated CEBPA that have a normal karyotype show favorable prognosis. In sporadic CEBPA mutation-associated AML, mutations are present only in the leukemic cells. Genetic testing to identify germ line mutations should not be performed on blood or bone marrow during acute episodes of AML. Other samples: buccal swab, saliva, skin biopsy or cultured fibroblast cells should be considered during these episodes.
- Absence of germ line CEBPA mutations in cases of AML indicates AML due to other causes
- Absence of germ line CEBPA mutations in cases of AML indicates poor prognosis
- Presence of heterozygous germ line CEBPA mutations in a case of AML in non-leukemic cells is diagnostic of Familial acute myeloid leukemia with mutated CEBPA
- Clustering of heterozygous germ line CEBPA mutations across affected family members is also diagnostic of Familial acute myeloid leukemia with mutated CEBPA.
Negative for mutation analyze (No reportable variants were identified)
Whole blood in EDTA.
Stability
- Room: 3-5 days
- Refrigerated: 7-14 days
Other specimens: Saliva, Buccal swab, skin biopsy, cultured dendritic cells.
- Indian J Hematol Blood Transfus. 2016 Dec; 32(4): 405–411. [PMID: 27812248]
- GeneReviews [Internet].Adam MP, Ardinger HH, Pagon RA, et al., editors. Seattle (WA): University of Washington, Seattle; 1993-2019. [PMID: 20301700]
- Blood Cancer J. 2014 Jul; 4(7): e226. [PMID: 25014773]
- Blood. 2009 Jun 25; 113(26): 6558–6566. [PMID: 19304957]
- Haematologica. 2011 Mar; 96(3): 384–392. [PMID: 21134981]
- Semin Hematol. 2017 Apr; 54(2):87-93. [PMID: 28637622]
- Atlas of Hematopathology: Morphology, Immunophenotype, Cytogenetics, and Molecular Approaches 1st Edition, 2013 Elsevier Inc. ISBN-13: 978-0123851833